brand logo

Am Fam Physician. 2004;69(1):164

Clinical Question: Does candesartan effectively reduce mortality and prevent hospitalizations in patients with congestive heart failure (CHF) who have an ejection fraction greater than 40 percent?

Setting: Outpatient (any)

Study Design: Randomized controlled trial (double-blinded)

Synopsis: In this part of the Cardiovascular Health and Risk Measurement trio of studies, patients with New York Heart Association class II or worse CHF with an ejection fraction greater than 40 percent were randomly assigned (masked allocation) to receive treatment with candesartan (n =1,514) or placebo (n = 1,509). The initial dosage, chosen by the study physician, was 4 mg or 8 mg of candesartan once daily or matching placebo. The dosage was doubled every two weeks to a target dosage of 32 mg once daily, if tolerated. Once the patients reached their target dosage, the investigators followed up every four months. The outcomes were assessed by intention-to-treat. Cardiovascular mortality and noncardiovascular mortality were the same in both groups, as was hospitalization for any cause. The study was powered to detect an 18 percent relative reduction in outcomes.

Bottom Line: In patients with CHF who have preserved left-ventricular function, candesartan has no meaningful effect on all-cause mortality or hospitalizations for any reason. (Level of Evidence: 1b)

POEMs (patient-oriented evidence that matters) are provided by Essential Evidence Plus, a point-of-care clinical decision support system published by Wiley-Blackwell. For more information, see Copyright Wiley-Blackwell. Used with permission.

For definitions of levels of evidence used in POEMs, see

To subscribe to a free podcast of these and other POEMs that appear in AFP, search in iTunes for “POEM of the Week” or go to

This series is coordinated by Natasha J. Pyzocha, DO, contributing editor.

A collection of POEMs published in AFP is available at

Continue Reading

More in AFP

Copyright © 2004 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP.  See permissions for copyright questions and/or permission requests.